Enhertu

Fam-Trastuzumab Deruxtecan-Nxki

7.8 High risk

Enhertu & Disease progression

10.5%

of users reported Disease progression

39.8%

also reported Severe reaction

72.1%

are women

Most common medical consequences

Severe reaction

39.8%

Hospitalization

30.7%

Death

27.7%

Disability

1.8%

Have you experienced any negative side effects from this medication?

Enhertu: general information

Most common side effects (66)

Most commonly affected ages

0 - 9 years

0.6%

10 - 19 years

<0.1%

20 - 29 years

<0.1%

30 - 39 years

6.1%

40 - 49 years

10.0%

50 - 59 years

25.4%

60 - 69 years

29.2%

70 - 79 years

26.0%

80 - 89 years

2.6%

On this page